Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263653
Status:
COMPLETED
Last Update Posted:
2016-09-21
First Post:
2005-12-08
Brief Title:
Safety Reactogenicity Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals Hib-MenC Given With Priorix in Toddlers 13-14 m Primed With 3 Doses of Hib and MenC-CRM197
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Haemophilus Influenzae Type b |
| Neisseria Meningitidis |
Keywords: